Duopharma Biotech Berhad reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was MYR 177.07 million compared to MYR 171.84 million a year ago. Net income was MYR 16.35 million compared to MYR 16.96 million a year ago. Basic earnings per share from continuing operations was MYR 0.0172 compared to MYR 0.018 a year ago. Diluted earnings per share from continuing operations was MYR 0.0172 compared to MYR 0.018 a year ago.
For the nine months, sales was MYR 544.76 million compared to MYR 493.73 million a year ago. Net income was MYR 52.95 million compared to MYR 49.97 million a year ago. Basic earnings per share from continuing operations was MYR 0.0559 compared to MYR 0.0531 a year ago. Diluted earnings per share from continuing operations was MYR 0.0559 compared to MYR 0.0531 a year ago.